Adjusted EPS Financial Overview
Operating Income
5.3
Operating Income
6.9
2.7
5.6
6.2
5.3
Adjusted Operating Income'
6.9
6.4
6.2
6.0
Q1 FY24
•
•
•
Operating income up 17.3% relative
to 7.6% growth in net sales
Net income margin decreased
~40bps and EBITDA margin'
increased ~30bps over last year
Q3 FY23 and Q4 FY23 negatively
affected by discrete charges of
$3.3B and $0.8B, respectively,
associated with the opioid legal
settlement frameworks, and
business reorganization and
restructurings
Q1 FY23
Q2 FY23
Q3 FY23 Q4 FY23
Q1 FY24
Q1 FY23
Q2 FY23
Q3 FY23
Q4 FY23
Y/Y Change
Y/Y Change (cc)'
-23.0%
-22.7%
-6.8%
-53.5%
-5.5%
+17.3%
-6.0%
-52.8%
-6.5%
+16.0%
Y/Y Change
Y/Y Change (cc)
-23.0%
-6.8%
+3.9%
+6.9%
+17.3%
-22.7%
-6.0%
+4.6%
+6.3%
+16.0%
'See additional information at the end of this presentation regarding non-GAAP financial measures.View entire presentation